| No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES *
[Number of genes] |
KEGG PATHWAY
[Number of pathways] |
Disease ID *
[Number of diseases] |
| 1 |
Abacavir |
Abacavir |
D00891, D07057 |
- |
- |
[3] 135, 265, 325 |
| 2 |
Baricitinib |
Baricitinib |
D10308 |
[2] JAK1, JAK2 |
[32] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
[8] 41, 46, 49, 50, 93, 107, 265, 325 |
| 3 |
Emtricitabine |
Emtricitabine |
D01199 |
- |
- |
[4] 25, 93, 265, 325 |
| 4 |
Lamivudine |
Lamivudine |
D00353 |
- |
- |
[6] 26, 42, 46, 135, 265, 325 |
| 5 |
Ly3009104 |
- |
- |
- |
- |
[4] 46, 49, 50, 325 |
| 6 |
Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir |
Lamivudine, Zidovudine |
D00353, D00413 |
- |
- |
[1] 325 |
| 7 |
Tenofovir |
Tenofovir |
D06074 |
- |
- |
[5] 2, 25, 93, 265, 325 |
| 8 |
Tenofovir (tdf) and emtricitabine (ftc) |
Emtricitabine |
D01199 |
- |
- |
[1] 325 |
| 9 |
Zidovudine |
Zidovudine |
D00413 |
- |
- |
[6] 25, 26, 135, 265, 325, 331 |